Alzheimer’s Disease in Alberta: Understanding the Current State and Readiness for Disease Modifying Therapies

Substance use disorders (SUD) affect one in five Canadians during their lifetime and are a leading cause of preventable morbidity and mortality. Common substances include alcohol, cannabis, opioids, prescription drugs, and cocaine.

Treatment options for people affected by schizophrenia have improved dramatically in the last 50 years but many people affected by schizophrenia do not receive the treatment they need. Of the over 360,000 Canadians affected by schizophrenia, only a third fully recover. People affected by schizophrenia die much earlier than the general population, mostly due to…

The goals of our research project are to identify ways to measure the quality of healthcare services provided to people living with dementia.    There are an increasing number of people living with dementia. Improving and maintaining quality of life is rated as the highest priority for people living with dementia and their caregivers. While many…

The population of Alberta is aging and there are increasing numbers of Albertans who are affected by Alzheimer’s disease and other types of dementia. At the present time little is known about the numbers of people affected by dementia in Alberta or how they interact with the health care system. Understanding the health care journeys…